Nurilla, Wadzna S.
HRN: 10-92-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2025
CEFUROXIME 1.5GM (VIAL)
06/14/2025
06/15/2025
IV
1.5g
Q8 X 2more Doses
Post Op Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes